WHO recommends more tests for Sanofi's dengue vaccine [Reuters]
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: Reuters
WHO recommends more tests for Sanofi's dengue vaccine | Reuters 4 Min Read PARIS/CHICAGO (Reuters) - The World Health Organization (WHO) said on Thursday Sanofi’s vaccine against dengue should only be used after testing on individuals to assess whether they have ever been exposed to the infection. After a two-day meeting in Geneva, Switzerland, experts at the U.N. agency recommended extra safety measures for the medicine. “We have now clear information that the vaccine needs to be dealt with in a much safer way by using it exclusively in people already infected with dengue before,” Alejandro Cravioto, Chair of the WHO’s Strategic Advisory Group of Experts (SAGE) on Immunization, told reporters. “It requires for the people to be tested through a system that is not currently available but that we feel will be developed in the next years,” he said. A spokeswoman for Sanofi had no immediate comment. The French drugmaker warned in November that the vaccine, first approved in late 2015 and
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- Sanofi (SNY) Q1 Earnings In Line, Sales Miss Estimates, Stock Up [Yahoo! Finance]Yahoo! Finance
- AbbVie reports positive results from Rinvoq versus Dupixent study [Seeking Alpha]Seeking Alpha
- UPDATE 1-European stocks slip as mixed earnings offset M&A cheer [Yahoo! Finance]Yahoo! Finance
- Life Sciences Market To Reach USD 9.6 Billion By 2032, Says DataHorizzon Research [Yahoo! Finance]Yahoo! Finance
- Sobi Q1 2024 report: Strong sales reflecting the strength of the portfolio [Yahoo! Finance]Yahoo! Finance
SNY
Analyst Actions
- 2/12/24 - TheStreet
SNY
Sec Filings
- 4/25/24 - Form 6-K
- 4/4/24 - Form F-3ASR
- 4/4/24 - Form S-8
- SNY's page on the SEC website